SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-290147
Filing Date
2020-11-10
Accepted
2020-11-10 16:09:31
Documents
12
Period of Report
2020-11-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d842059d8k.htm   iXBRL 8-K 38261
  Complete submission text file 0001193125-20-290147.txt   167120

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kdny-20201110.xsd EX-101.SCH 3073
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20201110_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20201110_pre.xml EX-101.PRE 11862
5 EXTRACTED XBRL INSTANCE DOCUMENT d842059d8k_htm.xml XML 3532
Mailing Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVE E. SEATTLE WA 98102 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 201301188
SIC: 2834 Pharmaceutical Preparations